M A Jesús Fdez-Aceñero

Learn More
BACKGROUND Neo-adjuvant chemoradiation therapy (CRTx) has become a standard therapeutic regimen for rectal carcinoma. This therapeutic option allows more sphincter preserving surgical procedures and seems to improve prognosis in patients with rectal carcinoma. The aim of this study is to analyse factors influencing prognosis in terms of disease free(More)
Neoadjuvant chemoradiation therapy is one of the standard therapeutic regimens for rectal carcinoma. Nevertheless, chemoradiation therapy is not completely devoid of adverse effects, and it would be interesting to try to predict which patient will respond to neoadjuvancy. This study aimed at analyzing factors influencing pathological response after therapy.(More)
PURPOSE To report the first case of metastasis from renal cell carcinoma to the lacrimal sac and review the therapeutic options. METHODS We have reviewed the case of a woman who was operated on for a renal cell carcinoma that developed epiphora and a lacrimal sac tumor, which corresponded to a metastasis from her previous tumor. Although renal cell(More)
  • 1